Cannabidiol (CBD) – An update

Subject Areas : Phytochemistry: Isolation, Purification, Characterization

Satyajit D. Sarker ¹ , Lutfun Nahar ²

1 - Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, United Kingdom
2 - Centre for Natural Products Discovery (CNPD), School of Pharmacy and Biomolecular Sciences, John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, United Kingdom|Laboratory of Growth Regulators, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech Republic

Received: 2020-01-20 Accepted : 2020-01-20 Published : 2020-03-01

Keywords:

References:

Corroon, J., Kight, R., 2018. Regulatory status of cannabidiol in the United States: A perspective. Cannabis Cannabinoid Res. 3, 190-194.

Lafaye, G., Karila, L., Blecha, L., Benyamina, A., 2017. Cannabis, cannabinoids, and health. Dialogues Clin. Neurosci.19, 309-316.

MedlinePlus, 2019. Cannabidiol. US National Library of Medicine. https://medlineplus.gov/druginfo/natural/1439.html (accessed on 22 December 2019).

Nahar, L., Onder, A., Sarker, S. D., 2020. A review on the recent advances in HPLC, UHPLC and UPLC analyses of naturally occurring cannabinoids (2010-2019). Phytochem. Anal. DOI: 10.1002/pca.2906